It has also been shown that the treatment of COPD patients with oral allopurinol, an inhibitor of xanthine oxidase, resulted in a significant reduction in airway reactive nitrogen species [29], indicating that this intervention may be useful in reducing the inflammatory and airway oxidative burst in chronic obstructive pulmonary disease. The gene discussed is XDH; the disease is chronic obstructive pulmonary disease.